The intersection of radiopharmaceuticals and nanotechnology has propelled the field of medicine forward, particularly concerning targeted cancer therapies. Image-guided nano-radiopharmaceuticals represent a promising new frontier in this context, offering the potential to administer therapeutic agents directly to cancer cells with high precision. This approach not only minimizes the impact on healthy tissues but also provides critical real-time feedback on treatment efficacy and systemic distribution, addressing significant limitations posed by conventional treatments such as non-specific toxicity and drug resistance. Recent advancements in imaging technologies and nanoparticle engineering have begun to overcome these obstacles, paving the way for more sophisticated and targeted cancer treatment strategies.
This Research Topic aims to explore and expand the horizons of image-guided nano-radiopharmaceuticals to enhance targeted cancer therapy. By integrating advanced imaging technologies with site-specific drug delivery systems, this field seeks to refine the precision of oncological treatments, thereby improving outcomes and decreasing adverse side effects. The goal is to identify key mechanisms that could further personalize cancer treatment, making it more efficient at a clinical level, while also exploring issues related to the scalability and accessibility of these technologies in real-world settings.
To gather further insights in the development and application of image-guided nano-radiopharmaceuticals, we welcome articles addressing, but not limited to, the following themes:
• Molecular targeting strategies in cancer theranostics
• Advances in nanoparticle design for improved imaging and therapy
• Preclinical and clinical case studies of nano-radiopharmaceutical applications
• Technological innovations in imaging for better drug delivery accuracy
• Challenges and opportunities in the clinical translation of nano-radiopharmaceuticals
These explorations are pivotal for realizing the full potential of nano-radiopharmaceuticals in the clinical landscape of cancer treatment.
Keywords: Radiopharmaceuticals, Nanotechnology, Theranostic Applications, Molecular targeting
Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
